| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |